These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35454070)

  • 1. In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets.
    Ricci F; Gitto R; Pitasi G; De Luca L
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
    Freidel MR; Armen RS
    PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach.
    Romeo I; Ambrosio FA; Costa G; Corona A; Alkhatib M; Salpini R; Lemme S; Vergni D; Svicher V; Santoro MM; Tramontano E; Ceccherini-Silberstein F; Artese A; Alcaro S
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase.
    White MA; Lin W; Cheng X
    J Phys Chem Lett; 2020 Nov; 11(21):9144-9151. PubMed ID: 33052685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
    Zeng J; Weissmann F; Bertolin AP; Posse V; Canal B; Ulferts R; Wu M; Harvey R; Hussain S; Milligan JC; Roustan C; Borg A; McCoy L; Drury LS; Kjaer S; McCauley J; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2405-2423. PubMed ID: 34198322
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Gurung AB
    Gene Rep; 2020 Dec; 21():100860. PubMed ID: 32875166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.
    Shu T; Huang M; Wu D; Ren Y; Zhang X; Han Y; Mu J; Wang R; Qiu Y; Zhang DY; Zhou X
    Virol Sin; 2020 Jun; 35(3):321-329. PubMed ID: 32500504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
    Habtemariam S; Nabavi SF; Banach M; Berindan-Neagoe I; Sarkar K; Sil PC; Nabavi SM
    Arch Med Res; 2020 Oct; 51(7):733-735. PubMed ID: 32536457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity.
    Mohammad TSH; Gupta Y; Reidl CT; Nicolaescu V; Gula H; Durvasula R; Kempaiah P; Becker DP
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ensemble cryo-EM reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication-transcription complex.
    Chen J; Wang Q; Malone B; Llewellyn E; Pechersky Y; Maruthi K; Eng ET; Perry JK; Campbell EA; Shaw DE; Darst SA
    Nat Struct Mol Biol; 2022 Mar; 29(3):250-260. PubMed ID: 35260847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase.
    Newman JA; Douangamath A; Yadzani S; Yosaatmadja Y; Aimon A; Brandão-Neto J; Dunnett L; Gorrie-Stone T; Skyner R; Fearon D; Schapira M; von Delft F; Gileadi O
    Nat Commun; 2021 Aug; 12(1):4848. PubMed ID: 34381037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase.
    Zhang C; Yu J; Deng M; Zhang Q; Jin F; Chen L; Li Y; He B
    Molecules; 2024 May; 29(10):. PubMed ID: 38792162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0.
    Gervasoni S; Vistoli G; Talarico C; Manelfi C; Beccari AR; Studer G; Tauriello G; Waterhouse AM; Schwede T; Pedretti A
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays.
    Inniss NL; Rzhetskaya M; Ling-Hu T; Lorenzo-Redondo R; Bachta KE; Satchell KJF; Hultquist JF
    SLAS Discov; 2024 Apr; 29(3):100145. PubMed ID: 38301954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Architecture of a SARS-CoV-2 mini replication and transcription complex.
    Yan L; Zhang Y; Ge J; Zheng L; Gao Y; Wang T; Jia Z; Wang H; Huang Y; Li M; Wang Q; Rao Z; Lou Z
    Nat Commun; 2020 Nov; 11(1):5874. PubMed ID: 33208736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling.
    Pitsillou E; Liang J; Hung A; Karagiannis TC
    J Mol Graph Model; 2022 Jul; 114():108193. PubMed ID: 35462185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents.
    Spratt AN; Gallazzi F; Quinn TP; Lorson CL; Sönnerborg A; Singh K
    Expert Opin Ther Pat; 2021 Apr; 31(4):339-350. PubMed ID: 33593200
    [No Abstract]   [Full Text] [Related]  

  • 18. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
    Li A; Zhang B; Zhao K; Yin Z; Teng Y; Zhang L; Xu Z; Liang K; Cheng X; Xia Y
    J Virol; 2023 Jul; 97(7):e0051223. PubMed ID: 37347173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors.
    El Hassab MA; Eldehna WM; Al-Rashood ST; Alharbi A; Eskandrani RO; Alkahtani HM; Elkaeed EB; Abou-Seri SM
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):563-572. PubMed ID: 35012384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.